These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Transmission assessment surveys in the Global Programme to Eliminate Lymphatic Filariasis: WHO position statement. Wkly Epidemiol Rec; 2012 Nov; 87(48):478-82. PubMed ID: 23213667 [No Abstract] [Full Text] [Related]
48. Translating Research into Reality: Elimination of Lymphatic Filariasis from Haiti. Lammie PJ; Eberhard ML; Addiss DG; Won KY; Beau de Rochars M; Direny AN; Milord MD; Lafontant JG; Streit TG Am J Trop Med Hyg; 2017 Oct; 97(4_Suppl):71-75. PubMed ID: 29064364 [TBL] [Abstract][Full Text] [Related]
49. Lymphatic filariasis: constraints ahead. Mishra CP; Singh N Indian J Public Health; 2003; 47(1):27-30. PubMed ID: 14723292 [No Abstract] [Full Text] [Related]
50. Knowledge, attitudes and perceptions regarding lymphatic filariasis: study on systematic noncompliance with mass drug administration. Cabral S; Bonfim C; Oliveira R; Oliveira P; Guimarães T; Brandão E; Aguiar-Santos AM; Medeiros Z Rev Inst Med Trop Sao Paulo; 2017 Apr; 59():e23. PubMed ID: 28443941 [TBL] [Abstract][Full Text] [Related]
51. Towards elimination of lymphatic filariasis: social mobilization issues and challenges in mass drug administration with anti-filarial drugs in Tamil Nadu, South India. Nandha B; Krishnamoorthy K; Jambulingam P Health Educ Res; 2013 Aug; 28(4):591-8. PubMed ID: 23503571 [TBL] [Abstract][Full Text] [Related]
55. Global programme to eliminate lymphatic filariasis: progress report for 2012. Wkly Epidemiol Rec; 2013 Sep; 88(37):389-99. PubMed ID: 24073461 [No Abstract] [Full Text] [Related]
56. Lymphatic filariasis: patients and the global elimination programme. Mackenzie CD; Lazarus WM; Mwakitalu ME; Mwingira U; Malecela MN Ann Trop Med Parasitol; 2009 Oct; 103 Suppl 1():S41-51. PubMed ID: 19843397 [TBL] [Abstract][Full Text] [Related]
57. A great success in lymphatic filariasis control in China. National Technical Steering Group for Filariasis Control and Research, MOPH. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1995; 13(2):81-5. PubMed ID: 7554168 [TBL] [Abstract][Full Text] [Related]
58. Impact of the 2004 mass drug administration for the control of lymphatic filariasis, in urban and rural areas of the Western province of Sri Lanka. Gunawardena GS; Ismail MM; Bradley MH; Karunaweera ND Ann Trop Med Parasitol; 2007 Jun; 101(4):335-41. PubMed ID: 17524248 [TBL] [Abstract][Full Text] [Related]
59. The sharp end - experiences from the Tanzanian programme for the elimination of lymphatic filariasis: notes from the end of the road. Malecela MN; Mwingira U; Mwakitalu ME; Kabali C; Michael E; Mackenzie CD Ann Trop Med Parasitol; 2009 Oct; 103 Suppl 1():S53-7. PubMed ID: 19843398 [TBL] [Abstract][Full Text] [Related]
60. Lymphatic filariasis control in Tanzania: infection, disease perceptions and drug uptake patterns in an endemic community after multiple rounds of mass drug administration. Derua YA; Kisinza WN; Simonsen PE Parasit Vectors; 2018 Jul; 11(1):429. PubMed ID: 30029675 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]